Publications 2024

Nørgaard JN, Moore KLF, Slørdahl TS, Vik A, Tvedt THA, Schjesvold F (2024)
VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study
Blood Cancer J, 14 (1), 60
DOI 10.1038/s41408-024-01047-1, PubMed 38594252

Røra M, Solberg MS, Moore KLF, Slørdahl TS (2024)
Incidence and prevention of skeletal-related events in multiple myeloma patients: A population-based real-world experience
EJHaem, 5 (4), 669-676
DOI 10.1002/jha2.928, PubMed 39157600

Publications 2023

Moore KLF, Turesson I, Genell A, Klausen TW, Knut-Bojanowska D, Redder L, Sverrisdottir I, Thorsen J, Vangsted AJ, Blimark CH (2023)
Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden
Haematologica, 108 (6), 1640-1651
DOI 10.3324/haematol.2021.280424, PubMed 36300775

Publications 2013

Moore KL, Kildahl-Andersen O, Kildahl-Andersen R, Tjønnfjord GE (2013)
Uncommon adverse effect of a common medication
Tidsskr Nor Laegeforen, 133 (2), 165
DOI 10.4045/tidsskr.12.0494, PubMed 23344600